Literature DB >> 22258045

Seizures as a manifestation of multiple sclerosis.

Jeffrey L Sponsler1, Anastasia C Kendrick-Adey.   

Abstract

The incidence of seizures is generally accepted to be greater in patients with multiple sclerosis (MS) than in the general population, and rarely, MS can initially present as seizure. To present a case report of seizure as the initial symptom of MS, to quantify the occurrence of seizures among MS patients, and to classify patients according to when seizures occur relative to onset of MS. The medical history of patients presenting with MS and seizure in our clinic was examined. In addition, 25 scientific papers were reviewed and the number and characteristics of patients with MS and seizure recorded. Data from the literature review and from our own clinical series were combined and examined. Of the MS patients, 1.95% experienced seizures at any time during life. Patients experiencing seizures before MS diagnosis were classified into three categories: (a) 25 (7.3% of patients with MS and seizures) with seizure as the initial presentation of MS; (b) 27 (7.9%) with seizures appearing with other signs and symptoms of MS; and (c) 68 (20%) with seizures occurring years or an unknown period of time before MS onset. Seizure occurring as a symptom of MS relapse was found in 29 patients. The prevalence of seizures among MS patients was higher than that in the general population, indicating a relationship between seizures and MS. Seizures occurred before MS diagnosis in a small percentage of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22258045     DOI: 10.1684/epd.2011.0468

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  6 in total

1.  Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Authors:  Lisa Langenbruch; Julia Krämer; Sati Güler; Gabriel Möddel; Sophia Geßner; Nico Melzer; Christian E Elger; Heinz Wiendl; Thomas Budde; Sven G Meuth; Stjepana Kovac
Journal:  J Neurol       Date:  2019-05-08       Impact factor: 4.849

Review 2.  The Endocannabinoid System and Oligodendrocytes in Health and Disease.

Authors:  Alexander A Ilyasov; Carolanne E Milligan; Emily P Pharr; Allyn C Howlett
Journal:  Front Neurosci       Date:  2018-10-26       Impact factor: 4.677

Review 3.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

4.  When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis.

Authors:  Breanna Taylor; Mallika P Patel; Katherine B Peters
Journal:  CNS Oncol       Date:  2021-01-15

5.  Jacksonian seizure as the relapse symptom of multiple sclerosis.

Authors:  Mohammad Reza Najafi; Ahmad Chitsaz; Mohammad Amin Najafi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

6.  Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study.

Authors:  Sherif M Hamdy; Maged Abdel-Naseer; Nevin M Shalaby; Alaa N Elmazny; Ahmed A Nemr; Amr Hassan; Mohamed I Hegazy; Husam S Mourad; Nirmeen A Kishk; Mona A Nada; Ahmed Abdelalim; Amr M Fouad; Hatem S Shehata
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-18       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.